Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 2,136,840 $ 1,506,647
Short-term investments   240,000
Accounts receivable, net 544,961 1,167,473
Inventories 141,956 118,205
Prepaid expenses and other assets 390,753 269,243
Total current assets 3,214,510 3,301,568
Property and equipment, net 13,532,399 13,528,806
Goodwill 98,134 98,134
Trade names 500,525 500,525
Other long-term assets 1,909,924 1,300,804
Total assets 19,255,492 18,729,837
Current liabilities:    
Current portion of long-term debt 1,009,741 876,890
Accounts payable 91,786 233,172
Accrued expenses and other liabilities 1,097,828 1,059,034
Advance ticket sales 1,977,325 1,561,336
Total current liabilities 4,176,680 3,730,432
Long-term debt 12,563,518 11,569,700
Other long-term liabilities 1,007,692 997,055
Total liabilities 17,747,890 16,297,187
Commitments and contingencies (Note 9)
Shareholders' equity:    
Ordinary shares, $0.001 par value; 980,000,000 shares authorized; 419,100,690 shares issued and outstanding at March 31, 2022 and 416,891,915 shares issued and outstanding at December 31, 2021 419 417
Additional paid-in capital 7,537,111 7,513,725
Accumulated other comprehensive income (loss) (250,808) (285,086)
Accumulated deficit (5,779,120) (4,796,406)
Total shareholders' equity 1,507,602 2,432,650
Total liabilities and shareholders' equity $ 19,255,492 $ 18,729,837